Aktieselskabet Schouw & Co.
1.9.2026 12:06:35 CEST | Globenewswire | Press release
Schouw & Co. closes the acquisition of Spectre and adjust revenue guidance accordingly
Schouw & Co. closes the acquisition of Spectre and adjust revenue guidance accordingly
On 2 July 2026, Schouw & Co. announced an agreement to acquire a majority stake in Spectre, a long-standing family-owned company and specialised B2B manufacturer of premium functional outdoor and sportswear apparel.
All the relevant regulatory approvals have now been obtained and all other conditions for the transaction have now been met. The transaction closed today as expected, and Schouw & Co. now holds a 75% ownership interest in Spectre, while the Klausen family remains the remaining 25%. The company will continue with its existing management.
The completed transaction will have the effect that Spectre will be recognised in the Schouw & Co. Group's consolidated financial statements from 1 September 2026. The consolidation of Spectre will expectedly increase the Group’s consolidated revenue for 2026 by DKK 300-400 million while no material impact is expected on EBITDA as the Purchase Price Allocation and other acquisition related costs will offset profits from ordinary activities. Consequently, the Group’s 2026 full-year revenue is now expected in the range of DKK 35.1-37.6 billion against previously DKK 34.8-37.2 billion, while the expectations for 2026 full-year EBITDA remains in the range DKK 3.150-3.350 million.
Before any effect of Purchase Price Allocations, etc., Spectre expects a full-year 2026 revenue of about DKK 1 billion and an EBITDA margin of 15–17%.
Aktieselskabet Schouw & Co.
Jørgen Wisborg, Chairman of the Board of Directors
Jens Bjerg Sørensen, President & CEO
Please direct any questions to President Jens Bjerg Sørensen, telephone no. +45 86 11 22 22.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SK pharmteco Inc.22.9.2026 15:03:00 CEST | Press release
SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone
Tenneco22.9.2026 15:00:53 CEST | Press release
Tenneco to Showcase Latest Railway Braking, Sliding Bearing and Systems Protection Solutions at InnoTrans 2026
AIM ImmunoTech Inc.22.9.2026 14:55:00 CEST | Press release
AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib
Nykredit Realkredit A/S22.9.2026 14:45:00 CEST | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
Nykredit Realkredit A/S22.9.2026 14:45:00 CEST | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom